1089 related articles for article (PubMed ID: 8754759)
1. Thyrotropin (TSH) receptor antibodies (TSHrAb) can inhibit TSH-mediated cyclic adenosine 3',5'- monophosphate production in thyroid cells by either blocking TSH binding or affecting a step subsequent to TSH binding.
Dallas JS; Cunningham SJ; Patibandla SA; Seetharamaiah GS; Morris JC; Tahara K; Kohn LD; Prabhakar BS
Endocrinology; 1996 Aug; 137(8):3329-39. PubMed ID: 8754759
[TBL] [Abstract][Full Text] [Related]
2. Dual mechanism of perturbation of thyrotropin-mediated activation of thyroid cells by antibodies to the thyrotropin receptor (TSHR) and TSHR-derived peptides.
Desai RK; Dallas JS; Gupta MK; Seetharamaiah GS; Fan JL; Tahara K; Kohn LD; Prabhakar BS
J Clin Endocrinol Metab; 1993 Sep; 77(3):658-63. PubMed ID: 8103771
[TBL] [Abstract][Full Text] [Related]
3. Thyrotropin (TSH) interacts with multiple discrete regions of the TSH receptor: polyclonal rabbit antibodies to one or more of these regions can inhibit TSH binding and function.
Dallas JS; Desai RK; Cunningham SJ; Morris JC; Seetharamaiah GS; Wagle N; Goldblum RM; Prabhakar BS
Endocrinology; 1994 Mar; 134(3):1437-45. PubMed ID: 8119184
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometric analyses of antibody binding to Chinese hamster ovary cells expressing human thyrotropin receptor.
Patibandla SA; Dallas JS; Seetharamaiah GS; Tahara K; Kohn LD; Prabhakar BS
J Clin Endocrinol Metab; 1997 Jun; 82(6):1885-93. PubMed ID: 9177401
[TBL] [Abstract][Full Text] [Related]
5. Receptor cross-talk can optimize assays for autoantibodies to the thyrotropin receptor: effect of phenylisopropyladenosine on adenosine 3',5'-monophosphate and inositol phosphate levels in rat FRTL-5 thyroid cells.
Hidaka A; Okajima F; Ban T; Kosugi S; Kondo Y; Kohn LD
J Clin Endocrinol Metab; 1993 Nov; 77(5):1164-9. PubMed ID: 8077307
[TBL] [Abstract][Full Text] [Related]
6. Use of cells expressing the human thyrotropin (TSH) receptor for the measurement of thyroid stimulating and TSH-blocking antibodies.
Vitti P; Chiovato L; Fiore E; Mammoli C; Rocchi R; Pinchera A
Acta Med Austriaca; 1996; 23(1-2):52-6. PubMed ID: 8767515
[TBL] [Abstract][Full Text] [Related]
7. Interaction of human chorionic gonadotropin (hCG) and asialo-hCG with recombinant human thyrotropin receptor.
Hoermann R; Broecker M; Grossmann M; Mann K; Derwahl M
J Clin Endocrinol Metab; 1994 Apr; 78(4):933-8. PubMed ID: 8157724
[TBL] [Abstract][Full Text] [Related]
8. The mechanism involved in the conversion of thyrotropin receptor-bound blocking-type immunoglobulin G (IgG) to the stimulating-type by anti-human IgG antibodies.
Taniguchi S; Yoshida A; Shigemasa C; Mitani Y; Ueta Y; Urabe K; Mashiba H
Endocrinology; 1990 Feb; 126(2):796-803. PubMed ID: 2153526
[TBL] [Abstract][Full Text] [Related]
9. The functional expression of recombinant human thyrotropin receptors in nonthyroidal eukaryotic cells provides evidence that homologous desensitization to thyrotropin stimulation requires a cell-specific factor.
Chazenbalk GD; Nagayama Y; Kaufman KD; Rapoport B
Endocrinology; 1990 Sep; 127(3):1240-4. PubMed ID: 2167212
[TBL] [Abstract][Full Text] [Related]
10. A human monoclonal autoantibody to the thyrotropin receptor with thyroid-stimulating blocking activity.
Sanders J; Evans M; Betterle C; Sanders P; Bhardwaja A; Young S; Roberts E; Wilmot J; Richards T; Kiddie A; Small K; Platt H; Summerhayes S; Harris R; Reeve M; Coco G; Zanchetta R; Chen S; Furmaniak J; Smith BR
Thyroid; 2008 Jul; 18(7):735-46. PubMed ID: 18631002
[TBL] [Abstract][Full Text] [Related]
11. Augmentative effect of polyethylene glycol, polyvinyl alcohol and dextran on thyroid-stimulating antibody stimulated cAMP production in FRTL-5 cells and CHO cells expressing human TSH receptor.
Ochi Y; Kajita Y; Wu L; Iidaka M; Nagayama Y
Horm Res; 2000; 53(1):20-5. PubMed ID: 10965216
[TBL] [Abstract][Full Text] [Related]
12. A region on the human thyrotropin receptor which can induce antibodies that inhibit thyrotropin-mediated activation of in vitro thyroid cell function also contains a highly immunogenic epitope.
Dallas JS; Seetharamaiah GS; Cunningham SJ; Goldblum RM; Desai RK; Prabhakar BS
J Autoimmun; 1994 Aug; 7(4):469-83. PubMed ID: 7980849
[TBL] [Abstract][Full Text] [Related]
13. Characterization of monoclonal thyroid-stimulating and thyrotropin binding-inhibiting autoantibodies from a Hashimoto's patient whose children had intrauterine and neonatal thyroid disease.
Kohn LD; Suzuki K; Hoffman WH; Tombaccini D; Marcocci C; Shimojo N; Watanabe Y; Amino N; Cho BY; Kohno Y; Hirai A; Tahara K
J Clin Endocrinol Metab; 1997 Dec; 82(12):3998-4009. PubMed ID: 9398703
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of a human monoclonal autoantibody to the thyrotropin receptor: sequence structure and function.
Sanders J; Jeffreys J; Depraetere H; Evans M; Richards T; Kiddie A; Brereton K; Premawardhana LD; Chirgadze DY; Núñez Miguel R; Blundell TL; Furmaniak J; Rees Smith B
Thyroid; 2004 Aug; 14(8):560-70. PubMed ID: 15320966
[TBL] [Abstract][Full Text] [Related]
15. Graves' immunoglobulins activate phospholipase A2 by recognizing specific epitopes on thyrotropin receptor.
Di Cerbo A; Di Paola R; Menzaghi C; De Filippis V; Tahara K; Corda D; Kohn LD
J Clin Endocrinol Metab; 1999 Sep; 84(9):3283-92. PubMed ID: 10487700
[TBL] [Abstract][Full Text] [Related]
16. Epitope heterogeneity of thyrotropin receptor-blocking antibodies in Graves' patients as detected with wild-type versus chimeric thyrotropin receptors.
Grasso YZ; Kim MR; Faiman C; Kohn LD; Tahara K; Gupta MK
Thyroid; 1999 Jun; 9(6):531-7. PubMed ID: 10411114
[TBL] [Abstract][Full Text] [Related]
17. Substitutions of different regions of the third cytoplasmic loop of the thyrotropin (TSH) receptor have selective effects on constitutive, TSH-, and TSH receptor autoantibody-stimulated phosphoinositide and 3',5'-cyclic adenosine monophosphate signal generation.
Kosugi S; Okajima F; Ban T; Hidaka A; Shenker A; Kohn LD
Mol Endocrinol; 1993 Aug; 7(8):1009-20. PubMed ID: 7901757
[TBL] [Abstract][Full Text] [Related]
18. The prevalence and clinical significance of blocking thyrotropin receptor antibodies in untreated hyperthyroid Graves' disease.
Kim WB; Chung HK; Park YJ; Park DJ; Tahara K; Kohn LD; Cho BY
Thyroid; 2000 Jul; 10(7):579-86. PubMed ID: 10958310
[TBL] [Abstract][Full Text] [Related]
19. The effect of thyrotropin-receptor blocking antibodies on stimulating autoantibodies from patients with Graves' disease.
Lenzner C; Morgenthaler NG
Thyroid; 2003 Dec; 13(12):1153-61. PubMed ID: 14751037
[TBL] [Abstract][Full Text] [Related]
20. The thyroid disruptor 1,1,1-trichloro-2,2-bis(p-chlorophenyl)-ethane appears to be an uncompetitive inverse agonist for the thyrotropin receptor.
Rossi M; Dimida A; Dell'anno MT; Trincavelli ML; Agretti P; Giorgi F; Corsini GU; Pinchera A; Vitti P; Tonacchera M; Maggio R
J Pharmacol Exp Ther; 2007 Jan; 320(1):465-74. PubMed ID: 17062616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
